We developed a monoclonal antibody (mAb-B7) that has high potential to become a potent drug that would be used in preventing and treating infections caused by antibiotic-resistant pathogens such as EPEC, EHEC and others.
UNMET NEED
It is predicted that a failure to address the problem of ...
1586128566.jpg)